These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

287 related items for PubMed ID: 22795543

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Fabrication of curcumin encapsulated PLGA nanoparticles for improved therapeutic effects in metastatic cancer cells.
    Yallapu MM, Gupta BK, Jaggi M, Chauhan SC.
    J Colloid Interface Sci; 2010 Nov 01; 351(1):19-29. PubMed ID: 20627257
    [Abstract] [Full Text] [Related]

  • 3. Engineered nanomedicine for myeloma and bone microenvironment targeting.
    Swami A, Reagan MR, Basto P, Mishima Y, Kamaly N, Glavey S, Zhang S, Moschetta M, Seevaratnam D, Zhang Y, Liu J, Memarzadeh M, Wu J, Manier S, Shi J, Bertrand N, Lu ZN, Nagano K, Baron R, Sacco A, Roccaro AM, Farokhzad OC, Ghobrial IM.
    Proc Natl Acad Sci U S A; 2014 Jul 15; 111(28):10287-92. PubMed ID: 24982170
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Surface functionalization of PLGA nanoparticles by non-covalent insertion of a homo-bifunctional spacer for active targeting in cancer therapy.
    Thamake SI, Raut SL, Ranjan AP, Gryczynski Z, Vishwanatha JK.
    Nanotechnology; 2011 Jan 21; 22(3):035101. PubMed ID: 21149963
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Bisphosphonate-functionalized coordination polymer nanoparticles for the treatment of bone metastatic breast cancer.
    He Y, Huang Y, Huang Z, Jiang Y, Sun X, Shen Y, Chu W, Zhao C.
    J Control Release; 2017 Oct 28; 264():76-88. PubMed ID: 28842315
    [Abstract] [Full Text] [Related]

  • 9. Low-molecular-weight protamine-modified PLGA nanoparticles for overcoming drug-resistant breast cancer.
    Wang H, Zhao Y, Wang H, Gong J, He H, Shin MC, Yang VC, Huang Y.
    J Control Release; 2014 Oct 28; 192():47-56. PubMed ID: 25003794
    [Abstract] [Full Text] [Related]

  • 10. Surface modification of poly(D,L-lactic-co-glycolic acid) nanoparticles with protamine enhanced cross-presentation of encapsulated ovalbumin by bone marrow-derived dendritic cells.
    Han R, Zhu J, Yang X, Xu H.
    J Biomed Mater Res A; 2011 Jan 28; 96(1):142-9. PubMed ID: 21105162
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Intracellular drug release from curcumin-loaded PLGA nanoparticles induces G2/M block in breast cancer cells.
    Verderio P, Bonetti P, Colombo M, Pandolfi L, Prosperi D.
    Biomacromolecules; 2013 Mar 11; 14(3):672-82. PubMed ID: 23350530
    [Abstract] [Full Text] [Related]

  • 14. Improved therapeutic effect of folate-decorated PLGA-PEG nanoparticles for endometrial carcinoma.
    Liang C, Yang Y, Ling Y, Huang Y, Li T, Li X.
    Bioorg Med Chem; 2011 Jul 01; 19(13):4057-66. PubMed ID: 21641806
    [Abstract] [Full Text] [Related]

  • 15. Injectable nanoparticle-loaded hydrogel system for local delivery of sodium alendronate.
    Posadowska U, Parizek M, Filova E, Wlodarczyk-Biegun M, Kamperman M, Bacakova L, Pamula E.
    Int J Pharm; 2015 May 15; 485(1-2):31-40. PubMed ID: 25747455
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The effect of surface functionalization of PLGA nanoparticles by heparin- or chitosan-conjugated Pluronic on tumor targeting.
    Chung YI, Kim JC, Kim YH, Tae G, Lee SY, Kim K, Kwon IC.
    J Control Release; 2010 May 10; 143(3):374-82. PubMed ID: 20109508
    [Abstract] [Full Text] [Related]

  • 18. Transferrin surface-modified PLGA nanoparticles-mediated delivery of a proteasome inhibitor to human pancreatic cancer cells.
    Frasco MF, Almeida GM, Santos-Silva F, Pereira Mdo C, Coelho MA.
    J Biomed Mater Res A; 2015 Apr 10; 103(4):1476-84. PubMed ID: 25046528
    [Abstract] [Full Text] [Related]

  • 19. Targeting cancer cells using PLGA nanoparticles surface modified with monoclonal antibody.
    Kocbek P, Obermajer N, Cegnar M, Kos J, Kristl J.
    J Control Release; 2007 Jul 16; 120(1-2):18-26. PubMed ID: 17509712
    [Abstract] [Full Text] [Related]

  • 20. Polymeric Nano-Encapsulation of Curcumin Enhances its Anti-Cancer Activity in Breast (MDA-MB231) and Lung (A549) Cancer Cells Through Reduction in Expression of HIF-1α and Nuclear p65 (Rel A).
    Khan MN, Haggag YA, Lane ME, McCarron PA, Tambuwala MM.
    Curr Drug Deliv; 2018 Feb 14; 15(2):286-295. PubMed ID: 29065834
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.